Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
Heart failure is a growing epidemic with high mortality rates and recurrent hospital admissions that creates a burden on affected individuals, their caregivers and the whole healthcare system. Throughout the years, many randomized trials have established the effectiveness of several pharmacological...
Saved in:
Main Authors: | Marilyne Jarjour (Author), Anique Ducharme (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
by: Jahanzeb Malik, et al.
Published: (2021) -
Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
by: Yiling Zhou, et al.
Published: (2021) -
Emerging concepts in heart failure management and treatment: focus on current guideline-directed medical therapy for heart failure with reduced ejection fraction
by: Oscar Eduardo Ospina González, et al.
Published: (2023) -
Plasma digoxin levels and ejection fraction in pediatric heart failure
by: Nafrialdi Nafrialdi, et al.
Published: (2016) -
New to paradigm for the treatment of heart failure with reduced ejection fraction?
by: Delfín Rodríguez Leyva
Published: (2015)